Loading the records…
Loading the records…
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, MIGNONE ROBERTO, holds the title of Director at TEVA PHARMACEUTICAL INDUSTRIES LTD.
On 2026-09-18, the insider transacted 367,600 shares.The shares were transacted at a weighted average price of $39.06 per share, resulting in a total market-relevant value of $14.4M.
MIGNONE ROBERTO (Director) sold $14.4M of $TEVA
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.